Compare IR & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IR | GEHC |
|---|---|---|
| Founded | 1859 | 1892 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Computer Software: Prepackaged Software |
| Sector | Industrials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.8B | 35.8B |
| IPO Year | 2017 | 2022 |
| Metric | IR | GEHC |
|---|---|---|
| Price | $85.74 | $74.87 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 12 |
| Target Price | ★ $99.86 | $91.17 |
| AVG Volume (30 Days) | ★ 3.9M | 2.9M |
| Earning Date | 05-15-2026 | 05-06-2026 |
| Dividend Yield | 0.09% | ★ 0.19% |
| EPS Growth | N/A | ★ 4.84 |
| EPS | 1.45 | ★ 4.55 |
| Revenue | $2,375,400,000.00 | ★ $20,625,000,000.00 |
| Revenue This Year | $7.23 | $7.06 |
| Revenue Next Year | $4.80 | $4.50 |
| P/E Ratio | $59.58 | ★ $16.40 |
| Revenue Growth | ★ 22.48 | 4.84 |
| 52 Week Low | $65.61 | $57.65 |
| 52 Week High | $100.96 | $89.77 |
| Indicator | IR | GEHC |
|---|---|---|
| Relative Strength Index (RSI) | 37.12 | 36.03 |
| Support Level | $78.21 | $69.34 |
| Resistance Level | $89.34 | $78.39 |
| Average True Range (ATR) | 2.52 | 2.19 |
| MACD | -1.38 | -0.83 |
| Stochastic Oscillator | 19.17 | 22.09 |
Ingersoll Rand was formed through the merger of Gardner Denver and Ingersoll Rand's industrial segment. The firm's portfolio consists of two business lines: industrial technologies and services, and precision and science technologies. Ingersoll Rand serves a variety of end markets, including industrial, medical, and energy. Its broad portfolio of products includes compression, blower and vacuum, and fluid management. Ingersoll Rand generated roughly $7.7 billion in revenue in 2025.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).